|
|
||||||||
Digestive Health Center of Excellence, University of Virginia, Charlottesville, VA 22908
Resident intestinal bacteria likely play an important role in the
pathogenesis of Crohns disease through their interaction with the gut
immune system. SAMP1/YitFc mice spontaneously develop chronic,
discontinuous, transmural ileitis with many features similar to
Crohns disease. The aim of this study was to determine the effects
and elucidate the mechanisms of action of antibiotic treatment in the
SAMP1/YitFc mouse model of ileitis. Mice were treated orally with
ciprofloxacin and metronidazole before the development of ileitis
(prevention protocol) or after ileitis was fully established (treatment
protocol). Terminal ilea were harvested for histological scoring, and
lamina propria and mesenteric lymph node cells were isolated for
analysis of activation markers and cytokine production. Antibiotic
therapy significantly decreased the severity of ileitis both in the
prevention (40% reduction, p < 0.05) and the
treatment (25% reduction, p < 0.01) protocols,
compared with untreated, control mice. These effects were associated
with a decreased percentage of CD4+/CD45RBhigh
lymphocytes in mesenteric lymph nodes of antibiotic-treated mice, as
well as decreased production of IFN-
(prevention: 0.53 ± 0.21
vs 1.84 ± 0.04 ng/ml, p < 0.05; treatment:
8.4 ± 0.4 vs 12.4 ± 0.7 ng/ml, p <
0.005) and TNF (prevention: 61.5 ± 13 vs 134 ± 19 pg/ml,
p < 0.01; treatment: 333.5 ± 11 vs 496
± 20 pg/ml, p < 0.001). The number of activated
lamina propria lymphocytes was also reduced after antibiotic treatment.
In conclusion, antibiotic therapy significantly ameliorates the
severity of ileitis in SAMP1/YitFc mice by a mechanism involving
down-regulation of activated gut lymphocytes and inhibition of
intestinal Th1 cytokine production.
This article has been cited by other articles:
![]() |
G. Bamias, A. Okazawa, J. Rivera-Nieves, K. O. Arseneau, S. A. De La Rue, T. T. Pizarro, and F. Cominelli Commensal Bacteria Exacerbate Intestinal Inflammation but Are Not Essential for the Development of Murine Ileitis J. Immunol., February 1, 2007; 178(3): 1809 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Heimesaat, S. Bereswill, A. Fischer, D. Fuchs, D. Struck, J. Niebergall, H.-K. Jahn, I. R. Dunay, A. Moter, D. M. Gescher, et al. Gram-Negative Bacteria Aggravate Murine Small Intestinal Th1-Type Immunopathology following Oral Infection with Toxoplasma gondii J. Immunol., December 15, 2006; 177(12): 8785 - 8795. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Prantera Probiotics for Crohn's disease: what have we learned? Gut, June 1, 2006; 55(6): 757 - 759. [Full Text] [PDF] |
||||
![]() |
T. Mueller, T. Terada, I. M. Rosenberg, O. Shibolet, and D. K. Podolsky Th2 Cytokines Down-Regulate TLR Expression and Function in Human Intestinal Epithelial Cells J. Immunol., May 15, 2006; 176(10): 5805 - 5814. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. S. Olson, B. K. Reuter, K. G-E. Scott, M. A. Morris, X.-M. Wang, L. N. Hancock, T. L. Burcin, S. M. Cohn, P. B. Ernst, F. Cominelli, et al. The primary defect in experimental ileitis originates from a nonhematopoietic source J. Exp. Med., March 20, 2006; 203(3): 541 - 552. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Mueller and A J Macpherson Layers of mutualism with commensal bacteria protect us from intestinal inflammation Gut, February 1, 2006; 55(2): 276 - 284. [Full Text] [PDF] |
||||
![]() |
H. K. Takahashi, H. Iwagaki, D. Xue, G. Katsuno, S. Sugita, K. Mizuno, S. Mori, S. Saito, T. Yoshino, N. Tanaka, et al. Effect of Ciprofloxacin-Induced Prostaglandin E2 on Interleukin-18-Treated Monocytes Antimicrob. Agents Chemother., August 1, 2005; 49(8): 3228 - 3233. [Abstract] [Full Text] [PDF] |
||||
![]() |
F Hoentjen, H J M Harmsen, H Braat, C D Torrice, B A Mann, R B Sartor, and L A Dieleman Antibiotics with a selective aerobic or anaerobic spectrum have different therapeutic activities in various regions of the colon in interleukin 10 gene deficient mice Gut, December 1, 2003; 52(12): 1721 - 1727. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |